Zeyad D Nassar

10PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biochemistry - lipidsCancer cell biologyCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 02, 2026
USP2 is an androgen-repressed survival factor that stabilises oncoproteins to facilitate therapy resistance in prostate cancer.

|Apr 24, 2024
ACSM1 and ACSM3 Regulate Fatty Acid Metabolism to Support Prostate Cancer Growth and Constrain Ferroptosis.

Raj K Shrestha, Zeyad D Nassar, Adrienne R Hanson

|Jun 08, 2022
Monounsaturated Fatty Acids: Key Regulators of Cell Viability and Intracellular Signaling in Cancer.

Julia S Scott, Zeyad D Nassar, Johannes V Swinnen

|Aug 07, 2021
Lipidomic Profiling of Clinical Prostate Cancer Reveals Targetable Alterations in Membrane Lipid Composition.

Lisa M Butler, Chui Yan Mah, Jelle Machiels

|Feb 06, 2021
ELOVL5 Is a Critical and Targetable Fatty Acid Elongase in Prostate Cancer.

Margaret M Centenera, Julia S Scott, Jelle Machiels

|Jul 21, 2020
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis.

Zeyad D Nassar, Chui Yan Mah, Jonas Dehairs

Pageof 2

Frequent Collaborators

8 joint publications

Lisa M Butler

5 joint publications

Chui Yan Mah

4 joint publications

Johannes V Swinnen

4 joint publications

Luke A Selth